Harnessing Novel Biology with a Next-Generation E3 Ligase in Targeted Protein Degradation
- Outlining insights from novel ligase discovery to degrader development
- Examining the biological differentiation beyond conventional CRBN and VHL E3 ligases
- Outlining how to enable safer degraders through reduced hematologic toxicity and improved therapeutic index